Dedicare (DEDI) Q3 2025 earnings summary

Executive summary

• Net sales for Q3 2025 were SEK 389.9 million, down 15.4% year-over-year, reflecting ongoing market challenges and price pressure in healthcare staffing.

• EBITA for Q3 rose to SEK 13.9 million, a 24.2% increase, with a margin of 3.6% due to effective savings measures.

• Strategic initiatives included the acquisition of We Care ApS in Denmark and expansion into physiotherapist and occupational therapist staffing in Sweden.

• Norway remains the largest market, accounting for over two-thirds of sales, but experienced a 16.5% sales decline year-over-year.

• The company maintains a strong financial position with an equity/assets ratio of 51.4%.

Financial highlights

• Q3 2025 net sales: SEK 389.9 million (down from SEK 460.9 million in Q3 2024).

• Q3 EBITA: SEK 13.9 million (up from SEK 11.2 million), EBITA margin 3.6% (2.4%).

• Profit for Q3: SEK 9.6 million (up from SEK 6.9 million).

• Jan–Sep 2025 net sales: SEK 1,093.0 million (down from SEK 1,330.7 million).

• Jan–Sep EBITA: SEK 37.4 million (down from SEK 49.8 million), EBITA margin 3.4% (3.7%).

• Cash and cash equivalents at period end: SEK 94.1 million (SEK 130.1 million in 2024).

Outlook and guidance

• Market conditions remain challenging with price pressure, limited demand, and intense competition, but signs of stabilization are emerging in Sweden.

• Investments in new segments and geographies are expected to enhance long-term competitiveness.

• The company is well-prepared for future growth, focusing on diversification and operational efficiency.